![Cynthia Sirard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Sirard
Chief Tech/Sci/R&D Officer at
COMPASS THERAPEUTICS, INC.
Net worth: 31 075 $ as of 2026-05-30
Profile
Cynthia Sirard is Chief Medical Officer at Compass Therapeutics, Inc. since 2026.
Formerly, Dr. Sirard was Chief Medical Officer at Cypherpunk Technologies, Inc. from 2020 to 2025 and Medical Director at PAREXEL International Corp.
from 2003 to 2005.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Chicago Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 27,500 ( 0.03% ) | 31 075 $ | 2026-05-30 |
Cynthia Sirard active positions
| Companies | Position | Start |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-12-31 |
Former positions of Cynthia Sirard
| Companies | Position | End |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Chief Tech/Sci/R&D Officer | 2025-07-30 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 2004-12-31 |
Training of Cynthia Sirard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
- Stock Market
- Insiders
- Cynthia Sirard
